The American Diabetes Association (ADA) now recommends that people with diabetes undergo a yearly screening to detect for early heart failure, even if they do not currently have any symptoms. The American College of Cardiology endorsed the new guidance, which calls for testing to detect elevated B-type natriuretic peptide levels and/or unusual levels of high-sensitivity cardiac troponin, which are known biomarkers of advanced stage heart failure in individuals with diabetes who are asymptomatic.

A new analysis finds that the uptake of 2021 U.S. Preventive Services Task Force (USPSTF) guidelines and 2022 American Diabetes Association (ADA) recommendations has had a positive effect on detection rates for prediabetes and undiagnosed diabetes.

CDC recently approved new pneumococcal vaccine (PCV) recommendations. Now, CDC recommends the use of either 20-valent pneumococcal conjugate vaccine (PCV20) alone or 15-valent pneumococcal conjugate vaccine (PCV15) in series with 23-valent pneumococcal polysaccharide vaccine (PPSV23) for all adults aged 65 years or older and for adults aged 19 to 64 years with certain underlying medical conditions or other risk factors who have not previously received a PCV vaccine or whose previous vaccination history is unknown.

PCSK9 inhibitors appear to lower nonfatal myocardial infarction in adults with high or very high cardiovascular risk but not in those with low or moderate risk, according to a new study published in The BMJ.

Antidepressants, including serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors, are widely used in the United States despite a number of unknowns related to their clinical performance. One of the biggest unknowns stems from the dearth of evidence on the efficacy of the drugs over the long term, as most studies have followed up with participants for only 8 to 12 weeks. Researchers also do not know much about how antidepressants affect mental and physical quality of life over time.